Omada Health, a chronic care company, just went public on the Nasdaq at a $1.1 billion valuation after 14 years of its founding.Its shares rose by over 38% above the initial price, indicating a successful public market debut.The IPO marked the second digital health IPO of the year, following Hinge Health's IPO in May.Omada Health saw its stock price open at $23 per share and jump to as high as $28.40 on the first trading day.The company initially gained recognition for its virtual care for prediabetes and diabetes management.Omada's business has expanded to include weight care, attracting clients interested in metabolic health management.Major investors like Revelation Partners, US Venture Partners, Andreessen Horowitz, Fidelity, Cigna Ventures, aMoon Fund, and Norwest Venture Partners saw significant returns post-IPO.CEO Sean Duffy's stake in the company is worth around $46 million, while president Wei-Li Shao's stake is valued at approximately $13 million.Omada's CFO, board members, and other executives also saw substantial gains from the IPO, with stakes ranging from $5.3 million to $380,000.The public debut marked a notable milestone for Omada Health and its stakeholders, showcasing the company's growth and investor confidence.